Optimised Pre-Analytical Methods Improve KRAS Mutation Detection in Circulating Tumour DNA (ctDNA) from Patients with Non-Small Cell Lung Cancer (NSCLC).

Optimised Pre-Analytical Methods Improve KRAS Mutation Detection in Circulating Tumour DNA (ctDNA) from Patients with Non-Small Cell Lung Cancer (NSCLC).

INTRODUCTION:Non-invasive mutation testing using circulating tumour DNA (ctDNA) is an attractive premise. This could enable patients without available tumour sample to access more treatment options. MATERIALS & METHODS:Peripheral blood and matched tumours were analysed from 45 NSCLC patients. We...

Full description

Bibliographic Details
Main Authors: James L Sherwood, Claire Corcoran, Helen Brown, Alan D Sharpe, Milena Musilova, Alexander Kohlmann
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4769175?pdf=render

Internet

http://europepmc.org/articles/PMC4769175?pdf=render

Similar Items